skinny.

Latest / The Podcast by KevinMD

Corporate greed and medical complicity fueled a $250,000 drug

Internal medicine and pulmonary physician Bharat Desai discusses his article "How Acthar Gel became a $250,000 drug." Bharat shares the shocking moment he realized an obsolete pituitary extract from 1952 was being sold for the price of a house. He explains how pharmaceutical companies exploited regulatory loopholes to reclassify a cheap animal derivative as a specialty biologic and effectively monopolize the market despite the existence of superior synthetic alternatives like prednisone. The conversation exposes the deep rot within the medical profession where key opinion leaders and…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.